To distinguish the subtypes of increased macrophages observed in the tumor-infiltrating lymphocytes analysis, we used MCP-1, CD80, and iNOS as M1 markers [37–39], while CD206 as an M2 marker [40]. The gene discussed is MRC1; the disease is neoplasm.